International Journal of Surgical Oncology最新文献

筛选
英文 中文
Implementation of a robotic surgical program in gynaecological oncology and comparison with prior laparoscopic series. 妇科肿瘤机器人手术方案的实施及与先前腹腔镜系列的比较。
IF 1.5
International Journal of Surgical Oncology Pub Date : 2015-01-01 Epub Date: 2015-02-15 DOI: 10.1155/2015/814315
Natalia Povolotskaya, Robert Woolas, Dirk Brinkmann
{"title":"Implementation of a robotic surgical program in gynaecological oncology and comparison with prior laparoscopic series.","authors":"Natalia Povolotskaya,&nbsp;Robert Woolas,&nbsp;Dirk Brinkmann","doi":"10.1155/2015/814315","DOIUrl":"https://doi.org/10.1155/2015/814315","url":null,"abstract":"<p><strong>Background: </strong>Robotic surgery in gynaecological oncology is a rapidly developing field as it offers several technical advantages over conventional laparoscopy. An audit was performed on the outcome of robotic surgery during our learning curve and compared with recent well-established laparoscopic procedure data.</p><p><strong>Method: </strong>Following acquisition of the da Vinci Surgical System (Intuitive Surgical, Inc., Sunnyvale, California, USA), we prospectively analysed all cases performed over the first six months by one experienced gynaecologist who had been appropriately trained and mentored. Data on age, BMI, pathology, surgery type, blood loss, morbidity, return to theatre, hospital stay, and readmission rate were collected and compared with a consecutive series over the preceding 6 months performed laparoscopically by the same team.</p><p><strong>Results: </strong>A comparison of two consecutive series was made. The mean age was somewhat different, 55 years in the robotic versus 69 years in the laparoscopic group, but obesity was a feature of both groups with a mean of BMI 29.3 versus 28.06, respectively. This difference was not statistically significant (P = 0.54). Three subgroups of minimal access surgical procedures were performed: total hysterectomy and bilateral salpingooophorectomy (TH + BSO), total hysterectomy and bilateral salpingooophorectomy plus bilateral pelvic lymphadenectomy (TH + BSO + BPLND), and radical hysterectomy plus bilateral pelvic lymphadenectomy (RH + BPLND). The mean time taken to perform surgery for TH + BSO was longer in the robotic group, 151.2 min compared to 126.3 min in the laparoscopic group. TH + BSO + BPLND surgical time was similar to 178.3 min in robotic group and 176.5 min in laparoscopic group. RH + BPLND surgical time was similar, 263.6 min (robotic arm) and 264.0 min (laparoscopic arm). However, the numbers in this initial analysis were small especially in the last two subgroups and do not allow for statistical analysis. The rate of complications necessitating intervention (Clavien-Dindo classification grade 2/3) was higher in the robotic arm (22.7%) compared to the laparoscopic approach (4.5%). The readmission rate was higher in the robotic group (18.2%) compared to the laparoscopic group (4.5%). The return to theatre in the robotic group was 18.2% and 4.5% in laparoscopic group. Uncomplicated robotic surgery hospital stay appeared to be shorter, 1.3 days compared to the uncomplicated laparoscopic group, 2.5 days. There was no conversion to the open procedure in either arm. Estimated blood loss in all cases was less than 100 mL in both groups.</p><p><strong>Conclusion: </strong>Robotic surgery is comparable to laparoscopic surgery in blood loss; however, the hospital stay in uncomplicated cases appears to be longer in the laparoscopic arm. Surgical robotic time is equivalent to laparoscopic in complex cases but may be longer in cases not requiring lymph node dissection. The ","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/814315","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33141113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Pelvic exenteration: experience from a rural cancer center in developing world. 盆腔切除:来自发展中国家农村癌症中心的经验。
IF 1.5
International Journal of Surgical Oncology Pub Date : 2015-01-01 Epub Date: 2015-02-08 DOI: 10.1155/2015/729658
Sampada B Dessai, Satheesan Balasubramanian, Vijay M Patil, Santam Chakraborty, Atanu Bhattacharjee, Syam Vikram
{"title":"Pelvic exenteration: experience from a rural cancer center in developing world.","authors":"Sampada B Dessai,&nbsp;Satheesan Balasubramanian,&nbsp;Vijay M Patil,&nbsp;Santam Chakraborty,&nbsp;Atanu Bhattacharjee,&nbsp;Syam Vikram","doi":"10.1155/2015/729658","DOIUrl":"https://doi.org/10.1155/2015/729658","url":null,"abstract":"<p><strong>Background: </strong>Pelvic exenteration (PE) is a morbid procedure. Ours is a rural based cancer center limited trained surgical oncology staff. Hence, this audit was planned to evaluate morbidity and outcomes of all patients undergoing PE at our center.</p><p><strong>Methods: </strong>This is a IRB approved retrospective audit of all patients who underwent PE at our center from January 2010 to August 2013. The toxicity grades were retrospectively assigned according to the CTCAE version 4.02 criteria. Chi-square test was done to identify factors affecting grades 3-5 morbidity. Kaplan Meier survival analysis has been used for estimation of median PFS and OS.</p><p><strong>Results: </strong>34 patients were identified, with the median age of 52 years (28-73 years). Total, anterior, posterior, and modified posterior exenterations were performed in 4 (11.8%), 5 (14.7%), 14 (41.2%), and 11 (32.4%) patients, respectively. The median time for surgery was 5.5 hours (3-8 hours). The median blood loss was 500 mL (200-4000 mL). CTCAE version 4.02 grades 3-4 toxicity was seen in nine patients (25.7%). The median estimated progression free survival was 31.76 months (25.13-38.40 months). The 2-year overall survival was 97.14%.</p><p><strong>Conclusion: </strong>PE related grades 3-5 morbidity of 25.7% and mortality of 2.9% at our resource limited center are encouraging.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/729658","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33103846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clear cell adenocarcinoma of the urethra: review of the literature. 尿道透明细胞腺癌:文献综述。
IF 1.5
International Journal of Surgical Oncology Pub Date : 2015-01-01 Epub Date: 2015-01-20 DOI: 10.1155/2015/790235
Anthony Kodzo-Grey Venyo
{"title":"Clear cell adenocarcinoma of the urethra: review of the literature.","authors":"Anthony Kodzo-Grey Venyo","doi":"10.1155/2015/790235","DOIUrl":"https://doi.org/10.1155/2015/790235","url":null,"abstract":"<p><strong>Background: </strong>Clear cell adenocarcinoma of the urethra (CCAU) is extremely rare and a number of clinicians may be unfamiliar with its diagnosis and biological behaviour.</p><p><strong>Aims: </strong>To review the literature on CCAU.</p><p><strong>Methods: </strong>Various internet databases were used.</p><p><strong>Results/literature review: </strong>(i) CCAU occurs in adults and in women in the great majority of cases. (ii) It has a particular association with urethral diverticulum, which has been present in 56% of the patients; is indistinguishable from clear cell adenocarcinoma of the female genital tract but is not associated with endometriosis; and probably does not arise by malignant transformation of nephrogenic adenoma. (iii) It is usually, readily distinguished from nephrogenic adenoma because of greater cytological a-typicality and mitotic activity and does not stain for prostate-specific antigen or prostatic acid phosphatase. (iv) It has been treated by anterior exenteration in women and cystoprostatectomy in men and at times by radiotherapy; chemotherapy has rarely been given. (v) CCAU is aggressive with low 5-year survival rates. (vi) There is no consensus opinion of treatment options that would improve the prognosis.</p><p><strong>Conclusions: </strong>Few cases of CCAU have been reported. Urologists, gynaecologists, pathologists, and oncologists should report cases of CCAU they encounter and enter them into a multicentric trial to determine the best treatment options that would improve the prognosis.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/790235","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33058132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 34
Now, later of never: multicenter randomized controlled trial call--is surgery necessary after atypical breast core biopsy results in mammographic screening settings? 现在,多中心随机对照试验呼吁——在乳房x光检查结果显示非典型乳房核心活检后,是否需要手术?
IF 1.5
International Journal of Surgical Oncology Pub Date : 2015-01-01 Epub Date: 2015-04-21 DOI: 10.1155/2015/192579
Nikita Makretsov
{"title":"Now, later of never: multicenter randomized controlled trial call--is surgery necessary after atypical breast core biopsy results in mammographic screening settings?","authors":"Nikita Makretsov","doi":"10.1155/2015/192579","DOIUrl":"https://doi.org/10.1155/2015/192579","url":null,"abstract":"<p><p>Breast cancer mammographic screening leads to detection of premalignant and preinvasive lesions with an increasing frequency. Nevertheless, current epidemiologic evidence indicates that the screening reduces breast cancer specific mortality, but not overall mortality in breast cancer patients. The evidence is lacking whether aggressive eradication of DCIS (preinvasive form of breast carcinoma) by surgery and radiation is of survival benefit, as long-term breast cancer specific mortality in a cohort of patients with DCIS is already in a single digit percent range. Furthermore, it is currently not known whether the aggressive surgical eradication of atypical breast lesions which fall short of diagnosis of DCIS is of any benefit for the patients. Here we propose a model for a randomized controlled trial to generate high level evidence and solve this dilemma. </p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/192579","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33306899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC. 腹膜癌:术中参数在开放(竞技场)与封闭腹部HIPEC。
IF 1.5
International Journal of Surgical Oncology Pub Date : 2015-01-01 Epub Date: 2015-02-15 DOI: 10.1155/2015/610597
E Halkia, A Tsochrinis, D T Vassiliadou, A Pavlakou, A Vaxevanidou, A Datsis, E Efstathiou, J Spiliotis
{"title":"Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC.","authors":"E Halkia,&nbsp;A Tsochrinis,&nbsp;D T Vassiliadou,&nbsp;A Pavlakou,&nbsp;A Vaxevanidou,&nbsp;A Datsis,&nbsp;E Efstathiou,&nbsp;J Spiliotis","doi":"10.1155/2015/610597","DOIUrl":"https://doi.org/10.1155/2015/610597","url":null,"abstract":"<p><strong>Background: </strong>Peritoneal carcinomatosis (PC) is associated with a poor prognosis. Cytoreductive surgery (CRS) and HIPEC play an important role in well-selected patients with PC. The aim of the study is to present the differences in the intraoperative parameters in patients who received HIPEC in two different manners, open versus closed abdomen.</p><p><strong>Patients and methods: </strong>The population includes 105 patients with peritoneal carcinomatosis from colorectal, gastric, and ovarian cancer, sarcoma, mesothelioma, and pseudomyxoma peritonei. Group A (n = 60) received HIPEC using the open technique and Group B (n = 45) received HIPEC with the closed technique. The main end points were morbidity, mortality, and overall hospital stay.</p><p><strong>Results: </strong>There were two postoperative deaths (3.3%) in the open group versus no deaths in the closed group. Twenty-two patients in the open group (55%) had grade III-IV complications versus 18 patients in the closed group (40%). There are more stable intraoperative conditions in the closed abdomen HIPEC in CVP, pulse rate, and systolic pressure parameters.</p><p><strong>Conclusions: </strong>Both methods are equal in the HIPEC procedures. Perhaps the closed method is the method of choice for frail patients due to more stable hemodynamic parameters.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/610597","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33141112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 39
Incisional surgical site infection after elective open surgery for colorectal cancer. 结直肠癌择期开放手术后切口手术部位感染。
IF 1.5
International Journal of Surgical Oncology Pub Date : 2014-01-01 Epub Date: 2014-03-27 DOI: 10.1155/2014/419712
Kosuke Ishikawa, Takaya Kusumi, Masao Hosokawa, Yasunori Nishida, Sosuke Sumikawa, Hiroshi Furukawa
{"title":"Incisional surgical site infection after elective open surgery for colorectal cancer.","authors":"Kosuke Ishikawa,&nbsp;Takaya Kusumi,&nbsp;Masao Hosokawa,&nbsp;Yasunori Nishida,&nbsp;Sosuke Sumikawa,&nbsp;Hiroshi Furukawa","doi":"10.1155/2014/419712","DOIUrl":"https://doi.org/10.1155/2014/419712","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to clarify the incidence and risk factors for incisional surgical site infections (SSI) in patients undergoing elective open surgery for colorectal cancer.</p><p><strong>Methods: </strong>We conducted prospective surveillance of incisional SSI after elective colorectal resections performed by a single surgeon for a 1-year period. Variables associated with infection, as identified in the literature, were collected and statistically analyzed for their association with incisional SSI development.</p><p><strong>Results: </strong>A total of 224 patients were identified for evaluation. The mean patient age was 67 years, and 120 (55%) were male. Thirty-three (14.7%) patients were diagnosed with incisional SSI. Multivariate analysis suggested that incisional SSI was independently associated with TNM stages III and IV (odds ratio [OR], 2.4) and intraoperative hypotension (OR, 3.4).</p><p><strong>Conclusions: </strong>The incidence of incisional SSI in our cohort was well within values generally reported in the literature. Our data suggest the importance of the maintenance of intraoperative normotension to reduce the development of incisional SSI.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/419712","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32318074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 32
Prognostic factors and survival in patients treated surgically for recurrent metastatic uterine leiomyosarcoma. 手术治疗复发性转移性子宫平滑肌肉瘤患者的预后因素和生存率。
IF 1.5
International Journal of Surgical Oncology Pub Date : 2014-01-01 Epub Date: 2014-06-22 DOI: 10.1155/2014/919323
Han L T Hoang, Kelsey Ensor, Gerald Rosen, H Leon Pachter, Joseph S Raccuia
{"title":"Prognostic factors and survival in patients treated surgically for recurrent metastatic uterine leiomyosarcoma.","authors":"Han L T Hoang,&nbsp;Kelsey Ensor,&nbsp;Gerald Rosen,&nbsp;H Leon Pachter,&nbsp;Joseph S Raccuia","doi":"10.1155/2014/919323","DOIUrl":"https://doi.org/10.1155/2014/919323","url":null,"abstract":"<p><strong>Background: </strong>Uterine leiomyosarcoma (LMS) is a rare diagnosis, which is seldom cured when it recurs with metastatic disease. We evaluated patients who present with first time recurrence treated surgically to determine prognostic factors associated with long-term survival.</p><p><strong>Methods: </strong>Over a 16-year period, 41 patients were operated on for recurrent uterine sarcoma. Data examined included patient age, date of initial diagnosis, tumor histology, grade at the initial diagnosis, cytopathology changes in tumor activity from the initial diagnosis, residual tumor after all operations, use of adjuvant therapy, dates and sites of all recurrences, and disease status at last followup.</p><p><strong>Results: </strong>24 patients were operated for first recurrence of metastatic uterine LMS. Complete tumor resection with histologic negative margins was achieved in 16 (67%) patients. Overall survival was significantly affected by the FIGO stage at the time of the initial diagnosis, the ability to obtain complete tumor resection at the time of surgery for first time recurrent disease, single tumor recurrence, and recurrence greater than 12 months from the time of the initial diagnosis. Median disease-free survival was 14 months and overall survival was 27 months.</p><p><strong>Conclusion: </strong>Our findings suggest that stage 1 at the time of initial diagnosis, recurrence greater than 12 months, isolated tumor recurrence, and the ability to remove ability to perform complete tumor resection at the time of the first recurrence can afford improved survival in selected patientsat the time of the first recurrence can afford improved survival in selected patients.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/919323","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32520022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Emergency surgery for metastatic melanoma. 转移性黑色素瘤的紧急手术
IF 1.5
International Journal of Surgical Oncology Pub Date : 2014-01-01 Epub Date: 2014-10-28 DOI: 10.1155/2014/987170
Dimitrios Mantas, Petros Tsaparas, Petros Charalampoudis, Helen Gogas, Gregory Kouraklis
{"title":"Emergency surgery for metastatic melanoma.","authors":"Dimitrios Mantas,&nbsp;Petros Tsaparas,&nbsp;Petros Charalampoudis,&nbsp;Helen Gogas,&nbsp;Gregory Kouraklis","doi":"10.1155/2014/987170","DOIUrl":"https://doi.org/10.1155/2014/987170","url":null,"abstract":"<p><p>Visceral metastases from malignant melanoma (stage M1c) confer a very poor prognosis, as documented on the most recent revised version of the TNM/AJCC staging system. Emergency surgery for intra-abdominal complications from the disease is rare. We report on our 5-year single institution experience with surgical management of metastatic melanoma to the viscera in the emergent setting. From 2009 to 2013, 14 patients with metastatic melanoma were admitted emergently due to an acute abdomen. Clinical manifestations encompassed intestinal obstruction and bleeding. Surgical procedures involved multiple enterectomies with primary anastomoses in 8 patients, and one patient underwent splenectomy, one adrenalectomy, one right colectomy, one gastric wedge resection, one gastrojejunal anastomosis, and one transanal debulking, respectively. The 30-day mortality was 7 percent. Median follow-up was 14 months. Median overall survival was 14 months. Median disease free survival was 7.5 months. One-year overall survival was 64.2 percent and 2-year overall survival was 14.2 percent. Emergency surgery for metastatic melanoma to the viscera is rare. Elective curative surgery combined with novel cytotoxic systemic therapies is under investigation in an attempt to grant survival benefit in melanoma patients with visceral disease. </p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/987170","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32925080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art. 晚期胃癌腹膜癌病的治疗:最新进展。
IF 1.5
International Journal of Surgical Oncology Pub Date : 2014-01-01 Epub Date: 2014-02-17 DOI: 10.1155/2014/912418
Giulia Montori, Federico Coccolini, Marco Ceresoli, Fausto Catena, Nicola Colaianni, Eugenio Poletti, Luca Ansaloni
{"title":"The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art.","authors":"Giulia Montori,&nbsp;Federico Coccolini,&nbsp;Marco Ceresoli,&nbsp;Fausto Catena,&nbsp;Nicola Colaianni,&nbsp;Eugenio Poletti,&nbsp;Luca Ansaloni","doi":"10.1155/2014/912418","DOIUrl":"https://doi.org/10.1155/2014/912418","url":null,"abstract":"<p><p>Gastric cancer (GC) is the fourth most common cancer and the second leading cause of cancer death in the world; 53-60% of patients show disease progression and die of peritoneal carcinomatosis (PC). PC of gastric origin has an extremely inauspicious prognosis with a median survival estimate at 1-3 months. Different studies presented contrasting data about survival rates; however, all agreed with the necessity of a complete cytoreduction to improve survival. Hyperthermic intraperitoneal chemotherapy (HIPEC) has an adjuvant role in preventing peritoneal recurrences. A multidisciplinary approach should be empowered: the association of neoadjuvant intraperitoneal and systemic chemotherapy (NIPS), cytoreductive surgery (CRS), HIPEC, and early postoperative intraperitoneal chemotherapy (EPIC) could increase the rate of completeness of cytoreduction (CC) and consequently survival rates, especially in patients with Peritoneal Cancer Index (PCI) ≤6. Neoadjuvant chemotherapy may improve survival also in PC from GC and adjuvant chemotherapy could prevent recurrence. In the last decade an interesting new drug, called Catumaxomab, has been developed in Germany. Two studies showed that this drug seems to improve progression-free survival in patients with GC; however, final results for both studies have still to be published. </p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/912418","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32230736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 87
The aetiology of delay to commencement of adjuvant chemotherapy following colorectal resection. 结直肠癌术后延迟开始辅助化疗的原因分析。
IF 1.5
International Journal of Surgical Oncology Pub Date : 2014-01-01 Epub Date: 2014-03-17 DOI: 10.1155/2014/670212
G S Simpson, R Smith, P Sutton, A Shekouh, C McFaul, M Johnson, D Vimalachandran
{"title":"The aetiology of delay to commencement of adjuvant chemotherapy following colorectal resection.","authors":"G S Simpson,&nbsp;R Smith,&nbsp;P Sutton,&nbsp;A Shekouh,&nbsp;C McFaul,&nbsp;M Johnson,&nbsp;D Vimalachandran","doi":"10.1155/2014/670212","DOIUrl":"https://doi.org/10.1155/2014/670212","url":null,"abstract":"<p><strong>Purpose: </strong>Timely administration of adjuvant chemotherapy following colorectal resection is associated with improved outcome. We aim to assess the factors which are associated with delay to adjuvant chemotherapy in patients who underwent colorectal resection as part of an enhanced recovery protocol.</p><p><strong>Method: </strong>A univariate and multivariate analysis of patient data collected as part of a prospectively maintained database of colorectal cancer patients between 2007 and 2012.</p><p><strong>Results: </strong>166 patients underwent colorectal resection followed by adjuvant chemotherapy. Median postoperative hospital stay was 6 days, and time to commencement of adjuvant chemotherapy was 50 days. Longer inpatient stay correlated with increased time to adjuvant chemotherapy (P = 0.05). Factors found to be independently associated with duration of hospital stay and time to commencement of adjuvant chemotherapy included stoma formation (P = 0.032), anastaomotic leak (P = 0.027), and preoperative albumin (P = 0.027). The use of laparoscopic surgery was associated with shorter time to adjuvant chemotherapy but did not reach significance (P = 0.143).</p><p><strong>Conclusion: </strong>A number of independent variables associated with delay to adjuvant therapy previously not described have been identified. Further work may be required to elucidate the effect that these variables have on long-term outcome.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/670212","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32285143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信